Skip to main content
Premium Trial:

Request an Annual Quote

AlgoNomics and Pevion Biotech to Develop Peptides for Cold Vaccine

NEW YORK, Feb. 25 (GenomeWeb News) - AlgoNomics and Pevion Biotech will collaborate to develop peptides for cold vaccines, the companies said today.

 

Over a period of a year and a half, structural bioinformatics company AlgoNomics, based in Ghent, Belgium, will use its Tripole protein modeling and peptide design technologies to develop peptides derived from Respiratory Syncytial Virus, which causes the common cold and other respiratory illnesses.

 

Pevion, of Bern, Switzerland, plans to formulate the peptides using its virosome technology and to test vaccine candidates in clinical trials.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.